SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Some behavioural and neurochemical aspects of subacute (±)3,4-methylenedioxymethamphetamine administration in rats
8 references·0 citing·25 second hop
Some behavioural and neurochemical aspects of subacute (±)3,4-methylenedioxymethamphetamine administration in rats (1995)Some behavioural and neurochemical aspect…Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (1990)Neurochemistry and Neurotoxic…Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observationsa (1990)Aminergic Metabolites in Cere…Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) (1988)Serotonergic-dopaminergic med…Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites (1988)Pharmacologic profile of MDMA…Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. (1988)Elevation of serum prolactin …(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates (1988)(+/-)3,4-Methylenedioxymetham…Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Neurotoxicity of the psychede…Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices (1986)Effects of enantiomers of MDA…Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue (1986)In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain (1987)Neurotoxicity of MDMA: Neurochemical Effects (1990)The Anxiogenic-Like and Anxiolytic-Like Effects of MDMA on Mice in the Elevated Plus-Maze A Comparison With Amphetamine (1999)Acute Psychological and Neurophysiological Effects of MDMA in Humans (2002)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks (2000)Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies (2000)Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects (2006)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human Brain (2002)Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users (2003)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations (1995)A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy (1997)The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) (2003)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals (2000)
this work references cited by second hop

References

  • 1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
  • 1986Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices307 cited
  • 1988Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites301 cited
  • 1988(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates300 cited
  • 1990Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)183 cited
  • 1988Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.179 cited
  • 1988Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)117 cited
  • 1990Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observationsa101 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work